TSCAN THERAPEUTICS INC (TCRX) Stock Balance Sheet
NASDAQ:TCRX - Nasdaq - US89854M1018 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 154.11M | 178.69M | 133.36M | 120.00M | 161.40M | |||
| Marketable Securities | 97.58M | 111.42M | 58.69M | N/A | N/A | |||
| Other Current Assets | 3.15M | 2.61M | 2.19M | 4.10M | 4.20M | |||
| Total Current Assets | 254.84M | 292.72M | 194.24M | 124.10M | 165.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 71.09M | 71.60M | 71.23M | 69.20M | 17.30M | |||
| Investments And Advances | 1.75M | 1.77M | 1.65M | 700.00K | 200.00K | |||
| Other Non-Current Assets | 5.03M | 5.03M | 5.03M | 5.00M | 5.00M | |||
| Total Non-Current Assets | 77.87M | 78.40M | 77.91M | 75.00M | 22.40M | |||
| TOTAL ASSETS | 332.71M | 371.12M | 272.15M | 199.10M | 188.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 3.35M | N/A | N/A | |||
| Accrued Expenses | 14.38M | 19.90M | 13.54M | 10.10M | 7.20M | |||
| Accounts Payable | 4.97M | 4.28M | 2.37M | 2.90M | 1.80M | |||
| Other Current Liabilities | 10.47M | 11.77M | 10.56M | 4.30M | 12.40M | |||
| Total Current Liabilities | 29.82M | 35.96M | 29.82M | 17.30M | 21.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 32.18M | 32.07M | 26.70M | 29.30M | 0.00 | |||
| Other Non-Current Liabilities | 60.51M | 62.12M | 64.76M | 53.10M | 6.00M | |||
| Total Non-Current Liabilities | 92.69M | 94.19M | 91.46M | 82.40M | 6.00M | |||
| TOTAL LIABILITIES | 122.51M | 130.15M | 121.28M | 99.70M | 27.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -409.22M | -375.10M | -247.60M | -158.40M | -92.20M | |||
| Additional Paid In Capital | 619.42M | 616.01M | 398.46M | 257.80M | 252.90M | |||
| Common Shares | 6.00K | 6.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -4.00K | 51.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 56.59M | 56.59M | 47.83M | 24.20M | 23.90M | |||
| Tangible Book Value per Share | 3.71 | 4.26 | 3.15 | 4.11 | 6.73 | |||
| Total Shareholders' Equity | 210.20M | 240.97M | 150.87M | 99.40M | 160.80M | |||
| TOTAL LIABILITIES AND EQUITY | 332.71M | 371.12M | 272.15M | 199.10M | 188.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.15 | 0.13 | 0.18 | 0.29 | N/A | |||
| Current Ratio | 8.55 | 8.14 | 6.51 | 7.17 | 7.78 | |||
| Return On Assets (ROA) | -39.52% | -34.36% | -32.78% | -33.26% | -25.85% | |||
| Return On Equity (ROE) | -62.55% | -52.91% | -59.14% | -66.62% | -30.24% | |||
All data in USD , ROIC based on taxRate of 0.21